ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 132 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $408,000 | -40.5% | 15,050 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $686,000 | -39.8% | 15,050 | +10.3% | 0.00% | -33.3% |
| Q4 2021 | $1,139,000 | +39.2% | 13,650 | +2.6% | 0.00% | +50.0% |
| Q3 2021 | $818,000 | +15.7% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $707,000 | +31.9% | 13,300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $536,000 | -26.1% | 13,300 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $725,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 1,824,583 | $39,520,000 | 14.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,301,771 | $49,857,000 | 4.79% |
| Matrix Capital Management Company, LP | 9,199,973 | $199,271,000 | 3.81% |
| Integral Health Asset Management, LLC | 550,000 | $11,913,000 | 2.31% |
| Avidity Partners Management LP | 4,223,100 | $91,472,000 | 1.86% |
| Affinity Asset Advisors, LLC | 170,000 | $3,682,000 | 1.03% |
| Eventide Asset Management | 1,861,000 | $40,309,000 | 0.79% |
| Sofinnova Investments, Inc. | 583,357 | $12,636,000 | 0.74% |
| Nicholas Investment Partners, LP | 158,704 | $3,438,000 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 60,000 | $1,300,000 | 0.26% |